Fibrosis biomarkers as a predictive tool for clinical outcome in PLNR14Del patients

Back

EHRA Premium Access

Fibrosis biomarkers as a predictive tool for clinical outcome in PLNR14Del patients

Session: New diagnostic methods in EP III

Topic: Noninvasive Diagnostic Methods

Speaker: Ms S. Van Der Voorn (Utrecht, NL)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Ms Stephanie Van Der Voorn

University Medical Center Utrecht, Utrecht (Netherlands (The))

0 follower

5 more presentations in this session

Prevalence and clinical characteristics of patients presenting with phase 4 atrioventricular block.

Speaker: Doctor S. Bun (Nice, FR)

Could specific EKG markers identify a pharmacologically induced type 1 Brugada pattern? Insights from a large, single-centre cohort.

Speaker: Doctor L. Barbonaglia (Vercelli, IT)

A novel non-invasive electrocardiographic imaging technique facilitates the preprocedural diagnostic workup of patients with infrequent ventricular arrhythmias

Speaker: Mrs K. Lesina (Rotterdam, NL)

Technical and electrophysiological aspects of multisite cardiac stimulation through the access of the middle cardiac vein

Speaker: Mr A. Rosa Filho (Sao Paulo, BR)

The role of marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation.

Speaker: Doctor K. Vlachos (Bordeaux, FR)

Access the full session

New diagnostic methods in EP III

Speakers: Ms S. Van Der Voorn, Doctor S. Bun, Doctor L. Barbonaglia, Mrs K. Lesina, Mr A. Rosa Filho...

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources